The beneficial effects of tamoxifen in the prevention and treatment of breast cancer are compromised by an increased risk of endometrial polyps, hyperplasia, and cancer. Tamoxifen ismetabolized to an array of metabolites with estrogenic effects but also to reactive intermedi-ates that may form protein and DNA adducts. The aim of this study was to investigate cellular [3H]tamoxifen adduct formation by light microscopic autoradiography and cell stress by immunohistochemi-cal analysis of glucose-regulating protein 78 (GRP78), nuclear factor B (NF-B), and caspase 3 in human endometrial explants after short-term incubation with tamoxifen. The cellular expression of tamoxifen-metabolizing enzymes in human endometrial biopsy samples was also deter...
Tamoxifen elevates the risk of endometrial tumours in women and α-(N²-deoxyguanosinyl)- tamoxifen ad...
The cyclin-dependent kinase inhibitor, p27, has been shown to mediate cell growth arrest thereby sig...
Aim: To study the effects of tamoxifen on the proliferation index and oestrogen receptor (ER) and pr...
The nonsteroidal antiestrogen tamoxifen increases the risk of endometrial cancer; however, the mecha...
ifen is used as an adjuvant chemotherapeutic agent to treat hormone-dependent breast cancer and as a...
Tamoxifen has been used in the management of receptor-positive breast cancer for >20 years. Usage co...
Background: Although the nonsteroidal antiestrogen tamoxifen is used as an adjuvant chemotherapeutic...
Tamoxifen has been used in the management of receptor-positive breast cancer for >20 years. Usage co...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen remains a frontline treatment for hormone-responsive breast cancer despite its use being a...
AIM: The goal of this research was to determine the effects of estrogen, progester-one, a combinatio...
Tamoxifen elevates the risk of endometrial tumours in women and α-(N²-deoxyguanosinyl)- tamoxifen ad...
The cyclin-dependent kinase inhibitor, p27, has been shown to mediate cell growth arrest thereby sig...
Aim: To study the effects of tamoxifen on the proliferation index and oestrogen receptor (ER) and pr...
The nonsteroidal antiestrogen tamoxifen increases the risk of endometrial cancer; however, the mecha...
ifen is used as an adjuvant chemotherapeutic agent to treat hormone-dependent breast cancer and as a...
Tamoxifen has been used in the management of receptor-positive breast cancer for >20 years. Usage co...
Background: Although the nonsteroidal antiestrogen tamoxifen is used as an adjuvant chemotherapeutic...
Tamoxifen has been used in the management of receptor-positive breast cancer for >20 years. Usage co...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen is used as adjuvant treatment for postmenopausal breast cancer patients. The mechanism of ...
Tamoxifen increases endometrial cell proliferation and the incidence of endometrial cancer in postme...
Tamoxifen remains a frontline treatment for hormone-responsive breast cancer despite its use being a...
AIM: The goal of this research was to determine the effects of estrogen, progester-one, a combinatio...
Tamoxifen elevates the risk of endometrial tumours in women and α-(N²-deoxyguanosinyl)- tamoxifen ad...
The cyclin-dependent kinase inhibitor, p27, has been shown to mediate cell growth arrest thereby sig...
Aim: To study the effects of tamoxifen on the proliferation index and oestrogen receptor (ER) and pr...